(295 days)
Not Found
No
The description details a standard oscillometric blood pressure monitor with a microprocessor and a "pressurement algorithm" for processing readings and compensating for artifacts. There is no mention of AI, ML, or any learning capabilities. The algorithm appears to be a deterministic, rule-based system.
No
The device is intended for measurement and monitoring of blood pressure, not for direct therapeutic intervention. It serves as an adjunct to medical management.
Yes
The device is intended for the noninvasive measurement of systolic and diastolic blood pressure and determination of heart rate, which are measurements used to establish a diagnosis of hypertension or monitor blood pressure in patients with known hypertension. Therefore, it provides information for diagnostic purposes.
No
The device description clearly outlines hardware components such as an air pump, electromagnetic valve, LCD display, pushbutton controls, and battery power, indicating it is a physical medical device with embedded software, not a software-only device.
Based on the provided information, the WS-300 system is not an IVD (In Vitro Diagnostic) device.
Here's why:
- Intended Use: The intended use clearly states the device is for "noninvasive measurement of systolic and diastolic blood pressure and determination of heart rate in adult patients." This involves measuring physiological parameters directly from the patient's body.
- Device Description: The description details a system that uses the oscillometric method to measure blood pressure at the wrist. This is a physical measurement technique.
- No mention of biological samples: IVD devices are designed to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening. There is no mention of the WS-300 system interacting with or analyzing any biological samples.
Therefore, the WS-300 system falls under the category of a non-invasive physiological monitoring device, not an IVD.
N/A
Intended Use / Indications for Use
The WS-300 system is intended for the noninvasive measurement of systolic and diastolic blood pressure and determination of heart rate in adult patients. The product is recommended for use by patients with labile blood pressure or known hypertension in a home care environment as an adjunct to medical management.
Product codes
74 DXN
Device Description
General: The WS-300 system is an automatic sphygmomanometer intended for measurement of blood pressure at the wrist using the oscillometric method. The entire system, including the cuff, is a single wrist-mounted unit. The system is microprocessor controlled and includes an air pump, an electromagnetic valve to regulate deflation rate, circuitry to detect and process minute pressure oscillations, an LCD display of systolic and diastolic pressure readings followed by heart rate, and pushbutton controls. A memory circuit stores the seven most recent measurements for comparison.
Operation: The WS-300 system employs a pressurement algorithm designed to detect, filter, process, and store pressure readings. The algorithm has been evaluated for the ability to detect and compensate for artifacts and to vield reliable readings in the presence of cardiac arrhythmias. The electromagnetic deflation control valve maintains the deflation rate at a constant 4 mmHg/sec irrespective of differences in wrist size which would otherwise cause variation in the deflation rate.
Power: The unit is powered by two AA-size batteries and contains an indicator to alert the operator when battery charge is weak.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
wrist
Indicated Patient Age Range
adult patients
Intended User / Care Setting
patients with labile blood pressure or known hypertension in a home care environment as an adjunct to medical management.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The measurement performance of the two systems has been compared by injecting identical pulse wave data, and excellent agreement between results calculated by the subject device and the predicate device were demonstrated. Safety testing including maximum cuff pressure, stability under various operating and storage conditions, vibration and shock, and electromagnetic compatibility has been conducted, resulting in the determination that the subject device complies with all relevant safety standards. The results of performance tests showed the WS-300 to comply with measurement accuracy and cuff deflation requirements as stated in ANSVAAMI Standard SP10-1992. Software validation testing was performed and reported in accordance with applicable FDA guidance.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1130 Noninvasive blood pressure measurement system.
(a)
Identification. A noninvasive blood pressure measurement system is a device that provides a signal from which systolic, diastolic, mean, or any combination of the three pressures can be derived through the use of tranducers placed on the surface of the body.(b)
Classification. Class II (performance standards).
0
3/5/99
510(k) SUMMARY
MODEL WS-300 AUTOMATIC DIGITAL ELECTRONIC WRIST BLOOD PRESSURE MONITOR
-
- COMPANY INFORMATION. Name: Nihon Seimitsu Sokki Co., Ltd. Address: 2509-13 Nakago, Komochi-Mura, Kitagunma-Gun, Gunma-Ken 377-02, Japan Phone: (011) 81-278-20-2311 Contact:
-
- DEVICE IDENTIFICATION, Trade Name: Model WS-300 Automatic Digital Electronic Wrist Blood Pressure Monitor Common Name: Digital Wrist Blood Pressure Monitor Classification Name: Noninvasive Blood Pressure Measurement System, 74 DXN
-
- PREDICATE DEVICE. Nihon Seimitsu Sokki Co., Ltd.: Model WS-200 Automatic Digital Electronic Wrist Blood Pressure Monitor. K952494, SE decision 12/28/95.
-
- DEVICE DESCRIPTION. General: The WS-300 system is an automatic sphygmomanometer intended for measurement of blood pressure at the wrist using the oscillometric method. The entire system, including the cuff, is a single wrist-mounted unit. The system is microprocessor controlled and includes an air pump, an electromagnetic valve to regulate deflation rate, circuitry to detect and process minute pressure oscillations, an LCD display of systolic and diastolic pressure readings followed by heart rate, and pushbutton controls. A memory circuit stores the seven most recent measurements for comparison.
Operation: The WS-300 system employs a pressurement algorithm designed to detect, filter, process, and store pressure readings. The algorithm has been evaluated for the ability to detect and compensate for artifacts and to vield reliable readings in the presence of cardiac arrhythmias. The electromagnetic deflation control valve maintains the deflation rate at a constant 4 mmHg/sec irrespective of differences in wrist size which would otherwise cause variation in the deflation rate.
Power: The unit is powered by two AA-size batteries and contains an indicator to alert the operator when battery charge is weak.
-
- INTENDED USES. The WS-300 system is intended for the noninvasive measurement of systolic and diastolic blood pressure and determination of heart rate in adult patients. The product is recommended for use by patients with labile blood pressure or known hypertension in a home care environment as an adjunct to medical management.
-
- COMPARISON WITH PREDICATE DEVICE. The Model WS-300 is a modification of the previously approved Model WS-200 Wrist Blood Pressure Monitor. The intended use of the two systems is the same. The principle of operation (oscillometric measurement), the measurement algorithm, and many operating features are identical. The Model WS-300 differs from the WS-200 in that it is constructed as a single unit rather than with a separate cuff, in that includes an electromagnetic deflation rate control valve which insures a constant deflation rate in contrast to the variable deflation speed that occurs with the predicate device, and in that it requires two rather than four 1.5V batteries for power.
1
-
- PERFORMANCE DATA. The measurement performance of the two systems has been compared by injecting identical pulse wave data, and excellent agreement between results calculated by the subject device and the predicate device were demonstrated. Safety testing including maximum cuff pressure, stability under various operating and storage conditions, vibration and shock, and electromagnetic compatibility has been conducted, resulting in the determination that the subject device complies with all relevant safety standards. The results of performance tests showed the WS-300 to comply with measurement accuracy and cuff deflation requirements as stated in ANSVAAMI Standard SP10-1992. Software validation testing was performed and reported in accordance with applicable FDA guidance.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is a stylized image of an eagle or bird-like figure with three curved lines representing its body and wings.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAR - 5 1999
NIHOM SEIMITSU SOKKI CO., LTD c/o Mr. Robert D. Waxham Submission Correspondent Waxham Medical Writing 222 Institute Street Smithfield, VA 23430
Re: K981702 Blood Pressure Monitor Automatic Digital Electronic Wrist Requlatory Class: II (Two) 74 DXN Product Code: December 4, 1998 Dated: December 7, 1998 Received:
Dear Mr. Waxham:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the marked the dostantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices ehat have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls The general controls provisions of the provisions of the Act. Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions aqainst misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Requlation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
3
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed or babbandants in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Also, please note the regulation Compliance at (301) 594-4639. entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html."
Sincerely yours,
Thomas J. Callahan
Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
510(k) Number (if known):
Device Name: Model WS-300 Automatic Digital Electronic Wrist Blood Pressure Monitor
Indications For Use:
The WS-300 system is intended for the noninvasive measurement of systolic and diastolic blood pressure and determination of heart rate in adult patients. The product is recommended for use by patients with labile blood pressure or known hypertension in a home care environment as an adjunct to medical management.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Bhna Shanker
(Division Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devic 510(k) Number .
Prescription Use (Per 21 CFR 801.109)
・・・・・・・・・・・・・
ーーーーーーーーーーー
OR
Over-The-Counter Use √
00022